Suppr超能文献

人甲状旁腺激素氨基末端37个残基的氨基酸序列。

The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormone.

作者信息

Niall H D, Sauer R T, Jacobs J W, Keutmann H T, Segre G V, O'Riordan J L, Aurbach G D, Potts J T

出版信息

Proc Natl Acad Sci U S A. 1974 Feb;71(2):384-8. doi: 10.1073/pnas.71.2.384.

Abstract

The sequence of the amino-terminal 37 residues of human parathyroid hormone has been established. The hormone used in these studies was isolated in highly purified form from parathyroid adenomata and was subjected to automated degradation in a Beckman sequencer. A high-sensitivity sequencing procedure employing (35)S-labeled phenylisothiocyanate of high specific activity as the coupling agent was used. The sequence obtained differs from that of bovine parathyroid hormone in three of the first 37 positions, and from that of porcine parathyroid hormone in two positions. A single human-specific residue was found (asparagine 16). The sequence obtained differs at three positions (22, 28, and 30) from the structure for human parathyroid hormone reported recently by Brewer et al. [(1972) Proc. Nat. Acad. Sci. USA 69, 3585-3588] and synthesized by Andreatta et al. [(1973) Helv. Chim. Acta, 56, 470-473] We have carefully reviewed our data, reported here in detail, on the sequence positions in dispute. We must conclude, on the basis of all available data, that the structure that we propose is the correct structure. The objective resolution of these discrepancies in structural analysis through further chemical and immunochemical studies is important, since synthesis of human parathyroid hormone, in which there is widespread interest for physiological and clinical studies, must be based on the correct sequence of the human hormone if the peptide is to be genuinely useful.

摘要

人甲状旁腺激素氨基末端37个残基的序列已确定。这些研究中使用的激素是从甲状旁腺腺瘤中以高度纯化的形式分离出来的,并在贝克曼测序仪中进行自动降解。采用高比活性的(35)S标记苯异硫氰酸酯作为偶联剂的高灵敏度测序程序。所得序列在前37个位置中有3个与牛甲状旁腺激素的序列不同,有2个与猪甲状旁腺激素的序列不同。发现了一个单一的人类特异性残基(天冬酰胺16)。所得序列在3个位置(22、28和30)与布鲁尔等人[(1972年)《美国国家科学院院刊》69,3585 - 3588]最近报道并由安德雷塔等人[(1973年)《瑞士化学学报》56,470 - 473]合成的人甲状旁腺激素结构不同。我们仔细审查了我们在这里详细报道的关于有争议序列位置的数据。基于所有现有数据,我们必须得出结论,我们提出的结构是正确的结构。通过进一步的化学和免疫化学研究客观解决结构分析中的这些差异很重要,因为如果要使该肽真正有用,那么对生理和临床研究有广泛兴趣的人甲状旁腺激素的合成必须基于人激素的正确序列。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16b5/388010/267d537955e1/pnas00055-0149-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验